卵巢移行细胞癌：病例系列及文献综述
Transitional cell carcinoma of the ovary: case series and review of literature.
作者信息
Ingin Rajashree J, Andola Sainath K, Zubair Ashraf Ahmed
机构信息
Professor, Department of Pathology, M. R. Medical College , Gulbarga, India .
Professor & HOD, Department of Pathology, M. R. Medical College , Gulbarga, India .
出版信息
J Clin Diagn Res. 2014 Aug;8(8):FD07-8. doi: 10.7860/JCDR/2014/9104.4733. Epub 2014 Aug 20.
Abstract
Transitional cell carcinoma (TCC) of the ovary is a recently recognized, subtype of ovarian surface epithelial cancer; the pure form accounting for only 1% of surface epithelial tumors. It has been described as a primary ovarian carcinoma with definite urothelial features but no benign, metaplastic and/or proliferating Brenner tumor (BT) identified. Recognition of such tumours is important because of its rarity, favorable response to chemotherapy and an improved patient survival. A case series of primary TCC of the ovary (3 cases) with brief review of literature is being presented.
摘要
卵巢移行细胞癌（TCC）是一种最近才被认识到的卵巢表面上皮癌亚型；其纯形式仅占表面上皮肿瘤的1%。它被描述为一种具有明确尿路上皮特征的原发性卵巢癌，但未发现良性、化生和/或增生性勃勒纳瘤（BT）。认识到这类肿瘤很重要，因为其罕见性、对化疗的良好反应以及患者生存率的提高。本文报告了一组原发性卵巢TCC病例系列（3例）并对文献进行简要回顾。
相似文献
1
Transitional cell carcinoma of the ovary: case series and review of literature.
J Clin Diagn Res. 2014 Aug;8(8):FD07-8. doi: 10.7860/JCDR/2014/9104.4733. Epub 2014 Aug 20.
2
Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Am J Surg Pathol. 2003 Nov;27(11):1434-41. doi: 10.1097/00000478-200311000-00005.
3
Ovarian Brenner tumors and transitional cell carcinoma: recent developments.
Int J Gynecol Pathol. 1993 Apr;12(2):128-33. doi: 10.1097/00004347-199304000-00007.
4
A pure primary transitional cell carcinoma of the ovary: A rare case report with literature review.
Int J Appl Basic Med Res. 2016 Apr-Jun;6(2):140-2. doi: 10.4103/2229-516X.179026.
5
Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis.
Am J Surg Pathol. 2004 Apr;28(4):453-63. doi: 10.1097/00000478-200404000-00004.
6
Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Virchows Arch. 2001 Feb;438(2):181-91. doi: 10.1007/s004280000315.
7
Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
Int J Gynecol Pathol. 1987;6(1):29-39. doi: 10.1097/00004347-198703000-00004.
8
Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Am J Surg Pathol. 2009 Mar;33(3):347-53. doi: 10.1097/PAS.0b013e3181908e24.
9
[Clinicopathologic features observation of ovarian transitional cell tumors].
Zhonghua Bing Li Xue Za Zhi. 2015 Feb;44(2):118-22.
10
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
Int J Gynecol Pathol. 2012 Nov;31(6):499-506. doi: 10.1097/PGP.0b013e31824d7445.
引用本文的文献
1
Synchronous Urinary Bladder Urothelial Carcinoma and Transitional Cell Carcinoma of the Ovary: A Case Report.
Case Rep Oncol. 2023 Sep 14;16(1):912-918. doi: 10.1159/000533269. eCollection 2023 Jan-Dec.
2
A Rare Urothelial Malignant Transformation in a Mature Cystic Teratoma of the Ovary.
Cureus. 2021 Aug 18;13(8):e17285. doi: 10.7759/cureus.17285. eCollection 2021 Aug.
3
Malignant Brenner tumor: Two case reports.
Case Rep Womens Health. 2018 Oct 13;20:e00082. doi: 10.1016/j.crwh.2018.e00082. eCollection 2018 Oct.
4
Stage IIIC transitional cell carcinoma and serous carcinoma of the ovary have similar outcomes when treated with platinum-based chemotherapy.
J Turk Ger Gynecol Assoc. 2017 Mar 15;18(1):33-37. doi: 10.4274/jtgga.2016.0190.
本文引用的文献
1
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
Int J Gynecol Pathol. 2012 Nov;31(6):499-506. doi: 10.1097/PGP.0b013e31824d7445.
2
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel.
Gynecol Oncol. 2005 Apr;97(1):195-9. doi: 10.1016/j.ygyno.2004.12.047.
3
Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma.
Arch Pathol Lab Med. 2005 Feb;129(2):194-9. doi: 10.5858/2005-129-194-EREIPU.
4
Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis.
Am J Surg Pathol. 2004 Apr;28(4):453-63. doi: 10.1097/00000478-200404000-00004.
5
Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Am J Surg Pathol. 2003 Nov;27(11):1434-41. doi: 10.1097/00000478-200311000-00005.
6
Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
Histopathology. 2000 May;36(5):433-8. doi: 10.1046/j.1365-2559.2000.00844.x.
7
Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Int J Gynecol Pathol. 1996 Jul;15(3):257-65. doi: 10.1097/00004347-199607000-00011.
8
Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy.
Am J Obstet Gynecol. 1993 Apr;168(4):1178-85; discussion 1185-7. doi: 10.1016/0002-9378(93)90365-p.
9
Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
Int J Gynecol Pathol. 1987;6(1):29-39. doi: 10.1097/00004347-198703000-00004.
10
Urothelial and ovarian carcinomas of identical cell types: problems in interpretation. A report of three cases and review of the literature.
Int J Gynecol Pathol. 1988;7(3):197-211. doi: 10.1097/00004347-198809000-00001.
Zotero 插件